Autonomix Medical (NASDAQ:AMIX) Stock Price Up 1.4% – Here’s Why

Shares of Autonomix Medical, Inc. (NASDAQ:AMIX) were up 1.4% on Tuesday . The stock traded as high as $4.64 and last traded at $4.29. Approximately 44,171 shares changed hands during mid-day trading, a decline of 74% from the average session volume of 166,781 shares. The stock had previously closed at $4.23.

Analysts Set New Price Targets

Several brokerages recently commented on AMIX. Weiss Ratings lowered Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a research report on Friday, July 10th. Zacks Research upgraded Autonomix Medical to a “hold” rating in a report on Tuesday, June 2nd. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $42.00.

Autonomix Medical Price Performance

The firm has a market capitalization of $2.33 million, a price-to-earnings ratio of -0.06 and a beta of -1.32. The business’s fifty day simple moving average is $7.15 and its 200 day simple moving average is $8.17.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.